No contamination was found in samples of eye drops made by India's Global Pharma Healthcare, a product linked to three deaths and blindness in some patients in the U.S., broadcaster NDTV reported on Tuesday citing India's health ministry sources.
Indian tests found the samples to be of "standard quality", the report said, nearly two months after U.S. agencies warned against using the Artificial Tears eye drops, citing potential contamination by drug-resistant bacteria.
Spokespeople for India's health ministry and Global Pharma Healthcare Pvt Ltd did not immediately respond to a request for comment.
